Follow
Anthony J Hatswell
Anthony J Hatswell
Other namesAnthony Batty
Analyst / Director, Delta Hat Limited
Verified email at deltahat.com - Homepage
Title
Cited by
Cited by
Year
Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014
AJ Hatswell, G Baio, JA Berlin, A Irs, N Freemantle
BMJ open 6 (6), e011666, 2016
1692016
Probabilistic sensitivity analysis in cost-effectiveness models: determining model convergence in cohort models
AJ Hatswell, A Bullement, A Briggs, M Paulden, MD Stevenson
Pharmacoeconomics 36, 1421-1426, 2018
912018
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
AJ Batty, RN Hansen, LM Bloudek, SF Varon, EJ Hayward, ...
Journal of medical economics 16 (7), 877-887, 2013
562013
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
RB Lipton, A Brennan, S Palmer, AJ Hatswell, JK Porter, S Sapra, G Villa, ...
Journal of medical economics 21 (7), 666-675, 2018
502018
Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: an economic impact analysis
HA Van Der Nelson, T Draycott, D Siassakos, CWH Yau, AJ Hatswell
European Journal of Obstetrics & Gynecology and Reproductive Biology 210 …, 2017
492017
Transparency in decision modelling: what, why, who and how?
CJ Sampson, R Arnold, S Bryan, P Clarke, S Ekins, A Hatswell, ...
Pharmacoeconomics 37 (11), 1355-1369, 2019
482019
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death
AJ Hatswell, B Pennington, L Pericleous, D Rowen, M Lebmeier, D Lee
Health and quality of life outcomes 12, 1-9, 2014
462014
Real-world evidence use in assessments of cancer drugs by NICE
A Bullement, T Podkonjak, MJ Robinson, E Benson, R Selby, AJ Hatswell, ...
International Journal of Technology Assessment in Health Care 36 (4), 388-394, 2020
372020
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
P Ghione, ML Palomba, AR Patel, S Bobillo, K Deighton, CA Jacobson, ...
Blood, The Journal of the American Society of Hematology 140 (8), 851-860, 2022
352022
Cost-effectiveness of trifluridine/tipiracil for previously treated metastatic colorectal cancer in England and Wales
A Bullement, S Underhill, R Fougeray, AJ Hatswell
Clinical colorectal cancer 17 (1), e143-e151, 2018
312018
The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam®) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When …
D Lee, D Gladwell, AJ Batty, N Brereton, E Tate
Pediatric Drugs 15, 151-162, 2013
312013
Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer
ER Marriott, G van Hazel, P Gibbs, AJ Hatswell
Journal of medical economics 20 (2), 193-199, 2017
292017
Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data
JN Zuckerman, AJ Batty, ME Jones
Travel medicine and infectious disease 7 (6), 329-336, 2009
242009
Cost effectiveness of avelumab for metastatic Merkel cell carcinoma
A Bullement, P Nathan, A Willis, A Amin, C Lilley, C Stapelkamp, ...
PharmacoEconomics-open 3, 377-390, 2019
232019
Cost effectiveness of characterised chondrocyte implantation for treatment of cartilage defects of the knee in the UK
J Elvidge, A Bullement, AJ Hatswell
Pharmacoeconomics 34, 1145-1159, 2016
232016
Reducing drug wastage in pharmaceuticals dosed by weight or body surface areas by optimising vial sizes
AJ Hatswell, JK Porter
Applied health economics and health policy 17, 391-397, 2019
222019
Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL
AJ Hatswell, S Vegter
Health economics review 6, 1-7, 2016
222016
The predicted impact of ipilimumab usage on survival in previously treated advanced or metastatic melanoma in the UK
J Larkin, AJ Hatswell, P Nathan, M Lebmeier, D Lee
PLoS One 10 (12), e0145524, 2015
202015
A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe
DC Lee, D Gladwell, AJ Hatswell, J Porter, N Brereton, E Tate, ...
Health economics review 4, 1-15, 2014
192014
The effects of model misspecification in unanchored matching-adjusted indirect comparison: results of a simulation study
AJ Hatswell, N Freemantle, G Baio
Value in Health 23 (6), 751-759, 2020
182020
The system can't perform the operation now. Try again later.
Articles 1–20